| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/13/2006 | US7060461 Genetic engineering; fusion protein |
| 06/13/2006 | US7060460 Purifying of polypeptide using continous chromatographic separation; chaperone polypeptides |
| 06/13/2006 | US7060459 TNF-inducible promoters and methods for using |
| 06/13/2006 | US7060451 Methods for screening GABA-modulatory compounds for specified pharmacological activities |
| 06/13/2006 | US7060449 Method of preparing GALR2 receptors composition |
| 06/13/2006 | US7060433 Methods and compositions for screening using diphtheria toxin constructs |
| 06/13/2006 | US7060276 Plasmodium falciparum AMA-1 protein and uses thereof |
| 06/13/2006 | US7060272 Death domain containing receptor-4 agonist antibodies and methods |
| 06/13/2006 | US7060270 Brain disorders; Alzheimer's disease; Down syndrome; hybridomas cell line; medical diagnosis |
| 06/13/2006 | US7060269 Anti-VEGF antibodies |
| 06/13/2006 | US7060268 Stability; freeze drying; regeneration |
| 06/13/2006 | CA1341508C Transforming growth factor peptides |
| 06/08/2006 | WO2006060743A2 Glucose-transport related genes, polypeptides, and methods of use thereof |
| 06/08/2006 | WO2006060643A2 Novel bladder matrix protein peptides and methods of detection of bladder cancer |
| 06/08/2006 | WO2006060630A2 Apparatuses and methods for determining protease activity |
| 06/08/2006 | WO2006059712A1 Monoclonal antibody binding to human steroid sulfatase |
| 06/08/2006 | WO2006059709A1 Novel gst tag sequence and utilization of the same |
| 06/08/2006 | WO2006059638A1 Anti-hiv drug, polypeptide constituting the same, gene encoding the polypeptide and method of producing the anti-hiv drug |
| 06/08/2006 | WO2006059433A1 Novel anthocyanidin glucosyltransferase gene |
| 06/08/2006 | WO2006043675A9 Cell extract for cell-free protein synthesis and method of preparing the extract |
| 06/08/2006 | WO2005115097A3 Cyclic peptide antibiotics |
| 06/08/2006 | WO2005092069A3 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
| 06/08/2006 | WO2005047487B1 Motoneuronotrophic factor gene sequences |
| 06/08/2006 | WO2005002527A3 Sirt1 modulation of adipogenesis and adipose function |
| 06/08/2006 | WO2003076571A3 Cancer-linked gene as target for chemotherapy |
| 06/08/2006 | US20060123509 Protein isolation and purification |
| 06/08/2006 | US20060123505 Full-length plant cDNA and uses thereof |
| 06/08/2006 | US20060123497 Sperm-specific cation channel, catsper-4, and uses therefor |
| 06/08/2006 | US20060122376 Protein complexes having factor VIII:C activity and production thereof |
| 06/08/2006 | US20060122375 Plant stress tolerance genes, and uses therefor |
| 06/08/2006 | US20060122374 Albumin-fused anti-angiogenesis peptides |
| 06/08/2006 | US20060122373 Delta3, FTHMA-070, Tango85, Tango77, SPOIL,NEOKINE, Tango129 and integrin alpha subunit protein and nucleic acid molecules and uses thereof |
| 06/08/2006 | US20060122372 Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications |
| 06/08/2006 | US20060122136 Effective and stable DNA enzymes |
| 06/08/2006 | US20060122135 Cloning and expression of a novel member of the Glial cell-line derived neurotrophic factors (GDNF); Parkinson's , Alzheimer's , Huntington's, Creutzfeld-Jacob diseases, neuropathic pain; acute brain injury, multiple sclerosis, amyotrophic lateral sclerosis, peripheral nerve trauma; cancer |
| 06/08/2006 | US20060122132 Use of murine genomic regions identified to be involved in tumor developement for the development of anti-cancer drugs and diagnosis of cancer |
| 06/08/2006 | US20060122117 Method of treating retinopathies and disorders associated with blood vessel loss |
| 06/08/2006 | US20060121588 Process for the biological production of 1,3-propanediol with high titer |
| 06/08/2006 | US20060121576 Maltose-1-phosphate-producing enzyme |
| 06/08/2006 | US20060121575 Methods for increasing the diversity of monoclonal antibodies produced against an antigen |
| 06/08/2006 | US20060121574 Recombinant method for making multimeric proteins |
| 06/08/2006 | US20060121573 Production of proteins |
| 06/08/2006 | US20060121572 Production of heterologous proteins in Caulobacter |
| 06/08/2006 | US20060121571 encode a polypeptide having oxalate degrading activity |
| 06/08/2006 | US20060121570 Methods for producing polypeptide binding sites, monoclonal antibodies and compositions thereof |
| 06/08/2006 | US20060121569 Providing a cell culture comprising; ammalian cells that contain a gene encoding TNFR-Ig, which gene is expressed under condition of cell culture; medium containing glutamine; maintaining culture in an initial growth phase, changing culture conditions, maintaining culture |
| 06/08/2006 | US20060121568 Production of polypeptides |
| 06/08/2006 | US20060121567 Infectious bursal disease virus (IBDV) variant from Georgia |
| 06/08/2006 | US20060121566 Stem cell expansion factor blocking gene limiting hox-induced expansion and method using such factor |
| 06/08/2006 | US20060121565 Methods for increasing the production of a recombinant polypeptide from a host cell |
| 06/08/2006 | US20060121564 Novel expression vector suitable for expression of recombinant protein at low temperature |
| 06/08/2006 | US20060121563 Novel tricistronic vectors and uses therefor |
| 06/08/2006 | US20060121562 Human receptor tyrosine kinase mertk |
| 06/08/2006 | US20060121561 Gene for increased somatic recombination |
| 06/08/2006 | US20060121560 DNA fragment to promote translation reaction and method for cell-free protein synthesis system using the same |
| 06/08/2006 | US20060121559 Purification instrument which can continuously and efficiently purify sugar chain; includes an immobilized protease column, immobilized glycopeptidase column |
| 06/08/2006 | US20060121552 Reporter protein fused to at least one protease cleavage sequence, and a linker for attaching the protease cleavage sequence to a solid support, can be used to quantitate protease activity, as well as be used to identify the type of protease being assayed |
| 06/08/2006 | US20060121528 Recombinant Candida rugosa lipases |
| 06/08/2006 | US20060121523 Transporter genes OATP-B, C, D, and E |
| 06/08/2006 | US20060121518 Polypeptide encoded by nucleic acid of given sequence; Glycerol-3-phosphate; modulators of cellular metabolism, energy homeostasis, signal transduction and cell proliferation |
| 06/08/2006 | US20060121514 Prostacyclin-stimulating Factor-2 |
| 06/08/2006 | US20060121513 Nuclear targeting sequence |
| 06/08/2006 | US20060121508 Alternatively spliced isoforms of purinergic receptor P2X, ligand-gated ion channel, subunits 3 and 4 (P2RX3, P2RX4) |
| 06/08/2006 | US20060121505 Beta chain-associated regulator of apoptosis |
| 06/08/2006 | US20060121482 Method for estimating the risk of carcinoma development |
| 06/08/2006 | US20060121480 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 06/08/2006 | US20060121475 Protein kinases |
| 06/08/2006 | US20060121471 Gene families associated with stomach cancer |
| 06/08/2006 | US20060121466 Hammerhead ribozymes |
| 06/08/2006 | US20060121460 Toll-like receptor 11 |
| 06/08/2006 | US20060121459 Receptors and membrane-associated proteins |
| 06/08/2006 | US20060121456 Isolated human ras-like proteins acid molecules encoding these human ras-like proteins, and uses thereof |
| 06/08/2006 | US20060121454 diagnosis and treatment of carcinomas, especially breast cancers |
| 06/08/2006 | US20060121042 Modulation of antibody specificity by tailoring the affinity to cognate antigens |
| 06/08/2006 | US20060121025 VEGF-related protein |
| 06/08/2006 | US20060121013 Use of negative regulatory elements for the neurospecific expression of transgenes |
| 06/08/2006 | US20060121009 Apparatus and method for machining michrochamber for cell culture |
| 06/08/2006 | US20060120996 Vaccine immunotherapy for immune suppressed patients |
| 06/08/2006 | CA2601629A1 Anti-hiv drug, polypeptide constituting the same, gene encoding the polypeptide and method of producing the anti-hiv drug |
| 06/08/2006 | CA2593429A1 The lupac bifunctional marker and its use in protein production |
| 06/08/2006 | CA2589902A1 Glucose-transport related genes, polypeptides, and methods of use thereof |
| 06/07/2006 | EP1666604A1 Compositions of orthogonal lysyl-tRNA and aminoacyl-tRNA synthetase pairs and uses thereof |
| 06/07/2006 | EP1666603A1 Method of synthesizing amino-acid-selectively labeled protein |
| 06/07/2006 | EP1666602A1 Method for the preparation of a heterologous protein, using yeast cells |
| 06/07/2006 | EP1666594A2 Polypeptide, nucleic acid encoding it, and their use for the diagnosis of cancer |
| 06/07/2006 | EP1666591A1 Cytokine that induces apoptosis |
| 06/07/2006 | EP1666587A1 Cyclic lipopeptide acylase |
| 06/07/2006 | EP1666501A1 Sugar chain-modified anti-hm1.24 antibody |
| 06/07/2006 | EP1666498A2 Soluble CTLA4 molecules, compositions comprising said molecules and uses thereof |
| 06/07/2006 | EP1666497A2 Polypeptide, nucleic acid encoding it, and their use for the diagnosis of cancer |
| 06/07/2006 | EP1666493A1 Secreted and transmembrane polypeptides and nucleic acids ancoding the same |
| 06/07/2006 | EP1666492A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2006 | EP1666491A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2006 | EP1666062A2 Therapeutic applications for the anti-T-BAM (CD40-L) monoclonal antibody 5c8 |
| 06/07/2006 | EP1666052A1 Uses of agonists and antagonists to modulate activity of TNF-related molecules |
| 06/07/2006 | EP1664321A2 Methods for expression and purification of immunotoxins |
| 06/07/2006 | EP1664320A2 Acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous yeasts |
| 06/07/2006 | EP1664292A2 Animal product free media and processes for obtaining a botulinum toxin |
| 06/07/2006 | EP1664278A1 Methods for producing recombinant proteins |
| 06/07/2006 | EP1664270A1 Chimeric antigens for breaking host tolerance to foreign antigens |